Clinical Trials · NCT02427295

Hormonal Outcomes in Acromegalic Patients With Treated Surgery With or Without Long Acting Somatostatin Analogues

UnknownPhase 4Octreotide (Unclear)
Phase
Phase 4
Recruitment status
Unknown
Sponsor
Asan Medical Center
Enrollment
1
Start date
Mar 2014
Locations
1 site, South Korea
Primary endpoint
Number of patients who achieved normalization of fasting serum IGF-1 (age and sex matched)
View Octreotide compound reference